VBIO NASDAQ
Valion Bio, Inc.
1W: -14.5%
1M: -17.0%
3M: +409.2%
YTD: +385.9%
$2.59
+0.08 (+3.19%)
Weekly Expected Move ±21.6%
$1
$2
$3
$3
$4
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Revenue Segmentation
By Product / Service
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
$0
+100.0% ▲
Operating Income
-$8M
-78.8% ▼
Net Income
-$9M
-57.0% ▼
EPS (Diluted)
$-7.84
+60.2% ▲
EBITDA
-$8M
-93.0% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2018 | FY2019 | FY2020 | FY2021 | FY2026 |
|---|---|---|---|---|---|
| Revenue | $102K | $0 | $0 | $0 | $0 |
| YoY Growth | -37.3% | -100.0% | +0.0% | +0.0% | +0.0% |
| Cost of Revenue | $78K | $0 | $0 | $0 | $0 |
| Gross Profit | $24K | $0 | $0 | $0 | $0 |
| Gross Margin | 23.9% | — | — | — | — |
| R&D Expenses | $2M | $2M | $1M | $409K | $3M |
| SG&A Expenses | $3M | $3M | $3M | $2M | $5M |
| Operating Expenses | $4M | $6M | $4M | $2M | $8M |
| Operating Income | -$4M | -$5M | -$4M | -$2M | -$8M |
| Operating Margin | -4292.9% | — | — | — | — |
| Interest Expense | $0 | $7K | $0 | $0 | $146K |
| Income Before Tax | -$4M | -$4M | -$4M | -$881K | -$8M |
| Tax Expense | $0 | $124K | $733K | $0 | $0 |
| Net Income | -$4M | -$20M | -$4M | -$881K | -$9M |
| Net Margin | -4207.2% | — | — | — | — |
| EPS (Diluted) | $-0.19 | $-0.61 | $-0.09 | $-0.02 | $-7.84 |
| EBITDA | -$4M | -$4M | -$4M | -$881K | -$8M |
| Shares Outstanding | 23M | 33M | 51M | 51M | 1M |